# How Should Investors Perform Structural AI Due Diligence in 2026?

aistructuralreview.com · September 30, 2026

> How Investors Should Perform Structural AI Due Diligence in 2026 Structural AI Due Diligence Goes Beyond Product Demos Also worth reading: How Do...

# How Investors Should Perform Structural AI Due Diligence in 2026

## Structural AI Due Diligence Goes Beyond Product Demos

**Also worth reading:** [How Do Physics-Informed Neural Networks Perform in Structural Reliability Analysis?](https://aistructuralreview.com/knowledge/how_do_physics-informed_neural_networks_perform_in_structural_reliability_analysis.php) · [What are the current AI structural estimation accuracy benchmarks and how do they perform in real-world engineering applications?](https://aistructuralreview.com/knowledge/what_are_the_current_ai_structural_estimation_accuracy_benchmarks_and_how_do_they_perform_in_real-world_engineering_applications.php) · [How do I perform a proper crawlspace moisture barrier installation to protect home structural integrity?](https://aistructuralreview.com/knowledge/how_do_i_perform_a_proper_crawlspace_moisture_barrier_installation_to_protect_home_structural_integrity.php)

Structural AI due diligence is the repeatable examination of the system that produces a company’s AI-related revenue: its data supply, model architecture, retrieval process, orchestration, evaluation program, infrastructure, security controls, contractual dependencies, human oversight, and production evidence. It is not a test of whether generated text sounds polished. Investors need to determine whether the product remains accurate, secure, economical, and compliant when inputs change, customers challenge it, software providers fail, or regulators request records.

The distinction matters because an impressive demonstration may conceal a brittle production architecture. A research prototype can rely on a short, curated dataset, while a commercial system processes millions of unfamiliar documents across multiple jurisdictions. It may use retrieval-augmented generation to make a third-party model appear specialized, yet fail when source documents become outdated or contradictory. A vendor may report strong customer satisfaction while concealing costly manual review, high model-inference expenses, or unresolved data rights.

For an investor, the purpose is not to reproduce the company’s internal technical review. It is to test whether the claimed value can survive ordinary commercial stress: customer growth, data migration, adversarial use, regulatory scrutiny, supplier outages, integration work, and rising compute costs. By 30 September 2026, that review should treat AI acquisitions as combinations of software, data, infrastructure capacity, contractual rights, operational processes, and regulatory exposure. A company that owns only an application layer may have less durable value than its valuation suggests, even if its product is commercially successful.

## Define What Is Actually Being Acquired

The first step is to establish precisely which AI asset the investment or acquisition will own. “We use AI” is not a sufficiently defined asset. The buyer should identify whether the relevant subject is a proprietary model, fine-tuned weights, a retrieval system, a workflow application, an evaluation dataset, a data license, a GPU cluster, an orchestration layer, or a combination of these. It should also determine whether the target owns the intellectual property outright or depends on contractual permission from another company.

This distinction affects valuation, transferability, and integration risk. A proprietary model can still be economically fragile if its training data cannot be used to rebuild or retrain the system. An application built around an API model may be portable in principle but expensive or legally restricted in practice. A customer-specific workflow can be valuable because it encodes process knowledge, yet it may become obsolete if the underlying vendor changes model behavior or pricing. Data-center capacity is not equivalent to compute access: a company may hold a long-term reservation without owning the hardware, while a stated “annualized compute cost” may exclude idle capacity, redundancy, networking, storage, and engineering labor.

Investors should trace the chain of title and control from raw data to customer output. Who collected the data, who licensed it, who transformed it, who owns the resulting embeddings or annotations, and who can transfer those rights in an acquisition? A 2026 review should also examine whether the target’s most valuable data is generated through customer use and whether those records can be used after a change of control. The answer affects both the durability of the product and the ability of a buyer to continue serving existing customers.

## Test the Data Foundation and Retrieval Architecture

Data is frequently presented as the company’s moat, but data volume alone does not establish defensibility. Diligence should examine provenance, coverage, freshness, representativeness, licensing, retention, and deletion practices. The team should ask how training, fine-tuning, retrieval, and product telemetry data differ, and whether the company can separate customer information, confidential business data, and personal data. It should verify claims about data exclusivity instead of accepting labels such as “proprietary” or “enterprise-grade” without documentation.

For retrieval systems, the critical questions concern what happens when the source changes. If a document is revised, deleted, superseded, or contradicted by another source, does the system surface the new information? Can the customer identify the document, passage, date, and permission supporting an answer? Is retrieval performed against an index that is actually refreshed, or against a stale snapshot? A system with a 95% answer-acceptance rate in a controlled test may perform materially worse when its knowledge base contains 10,000 documents, many with similar names and conflicting versions.

The investor should request metrics segmented by task, language, customer, document type, and risk level. Aggregate accuracy is often insufficient. A system that is 98% accurate on low-risk summarization but 70% accurate on contractual obligations may create more liability than a lower-performing tool used for internal navigation. The review should also examine whether the company has a defensible evaluation set created independently of product owners. In high-stakes uses such as credit, healthcare, employment, insurance, or legal services, the evaluation design may be more important than the model selection itself.

## Evaluate Models, Orchestration, and Failure Behavior

Model architecture should be evaluated as part of a larger system, not judged by parameter count or leaderboard position. Investors need to understand which tasks are handled by foundation models, smaller specialized models, rules, deterministic software, or human reviewers. They should identify where multiple models are chained together, where outputs are automatically written back to operational systems, and where an error can propagate without detection. A system may use five models and three agents, but the real risk lies in the handoffs among them rather than in any single model’s general benchmark score.

The review should include adversarial and failure-oriented testing. Can a user induce the system to reveal another customer’s information? Can malformed documents, prompt injection, poisoned files, or indirect instructions in retrieved content redirect the workflow? What happens when the model refuses, returns invalid structured output, or exceeds latency and cost limits? Does the system fail closed in a payment, hiring, medical, or compliance workflow, or does it fail open and allow an uncertain answer to proceed?

Investors should also examine change management. A model provider’s update can alter tone, refusal behavior, tool use, token consumption, or output structure without a change in the target’s source code. The company should maintain regression tests, version records, deployment gates, rollback procedures, and customer-specific acceptance criteria. A credible program might require evaluation on at least 100 representative tasks before each major model change, with severity-based thresholds for release. If no such process exists, the investor should treat model-provider changes as an unpriced operational risk.

## Measure Production Performance and Unit Economics

Pilot results are not evidence of scalable economics. The investor should request production data covering at least 12 months where available, including usage by customer, workflow completion, human escalation, latency, downtime, error rates, and cost per successful task. The key measure is not cost per query; it is cost per resolved business outcome. A legal review that saves 20 minutes but requires a lawyer to spend 10 minutes correcting the output may deliver little value, while a document-classification system that costs $0.40 per item and operates at scale may be commercially attractive.

The company should disclose how inference costs are allocated. Are model, retrieval, storage, labeling, evaluation, security, and support costs included in gross margin? What portion of revenue depends on premium models, reserved GPU capacity, or third-party APIs? If the vendor changes prices by 20%, can the company pass the increase to customers, reduce model usage, or maintain margins? Contract terms may make the economics look stronger than they are if usage is uncapped and the customer bears the cost, but that can also create disputes and limit adoption.

A useful sensitivity analysis should vary at least three variables: inference volume, model price, and human-review labor. A 25% increase in usage should not be presented merely as revenue growth if it also raises service costs faster than contract pricing. Investors should compare the target’s gross margin with conventional software benchmarks, but they should not assume every AI product deserves conventional software multiples. Compute-intensive systems may have lower gross margins, faster obsolescence, and greater working-capital needs than their interface suggests.

## Review Security, Privacy, and Regulatory Exposure

AI security diligence must cover both conventional cybersecurity and AI-specific attack paths. The target should provide an architecture diagram, threat model, incident history, penetration-test summaries, vulnerability-management metrics, access-control design, encryption practices, and disaster-recovery evidence. Access to training data, vector stores, prompts, evaluation results, and customer logs should be separated by role. Privileged operators should be logged, and production secrets should not be embedded in notebooks, source repositories, or employee-managed tools.

Investors should ask how the company handles personal data, confidential customer information, and regulated records across jurisdictions. The relevant obligations may include the EU AI Act, the UK’s evolving regulatory framework, sector-specific rules, contractual restrictions, and state or federal privacy requirements. The EU AI Act’s obligations are phased rather than simultaneous, with prohibited-practice and AI-literacy provisions applying earlier than many obligations for high-risk systems. A company therefore cannot responsibly answer the question simply by stating that its product is “compliant”; it should map intended uses, risk classifications, documentation, human oversight, and post-market monitoring to applicable deadlines.

The review should test whether the company can produce records for an individual decision. Can it reconstruct the input data, model and prompt versions, retrieval results, system logs, human interventions, and policy rules associated with a decision? The right to explanation, contestability, and remediation may depend on those records. The absence of reliable logs is a commercial weakness as well as a legal weakness: without them, the company may be unable to defend a decision, investigate an incident, or support an enterprise customer’s audit request.

## Compare Build, Buy, Fine-Tune, and Orchestrate

Investors often need to compare the target’s technical choices with alternatives rather than accept its architecture as inevitable. Building a foundation model from scratch may offer control but require substantial capital, specialized talent, and data that may not justify the cost. Fine-tuning may improve performance for a narrow domain but can create portability and maintenance burdens. Retrieval may provide current information and attribution without retraining, yet it introduces document-quality, indexing, and access-control problems. A managed API can accelerate launch but creates vendor dependence, price exposure, and potentially weak differentiation.

| Architectural choice | Principal advantage | Principal exposure | Diligence question |
| --- | --- | --- | --- |
| Build proprietary foundation model | Maximum control over behavior and possible differentiation | Capital cost, data quality, talent scarcity, rapid obsolescence | Is the model’s performance advantage large enough to justify rebuilding it? |
| Fine-tune an existing model | Can improve task-specific behavior with less infrastructure | Version drift, licensing, retraining and transfer risk | Can the target reproduce and govern the fine-tune? |
| Use a third-party API | Fast launch and often strong general capability | Supplier dependence, price changes, outages and data terms | What happens if the provider changes or terminates access? |
| Retrieval-augmented system | Uses current, attributable enterprise information | Stale sources, retrieval errors, prompt injection and permissions | Can every important answer be traced to a governed source? |
| Human-in-the-loop workflow | Better judgment for ambiguous or high-risk cases | Labor cost, inconsistency, latency and scalability | What proportion of outcomes actually receive meaningful review? |

The comparison should be specific to the target’s economics and customers. A system that is technically inferior in a benchmark may be commercially superior if it is cheaper, easier to audit, or integrated into an existing workflow. Conversely, a sophisticated model can be a poor investment if its advantage disappears when the customer’s documents are messy or when a more capable general model becomes available at a lower price.

## Common Due Diligence Mistakes and How to Avoid Them

One common mistake is treating vendor-produced benchmarks as independent evidence. Benchmarks can be narrow, contaminated by training data, or selected after the fact. Investors should ask for the test set, scoring rules, baseline systems, failure cases, and the identities of the people who designed the evaluation. Another mistake is accepting a product metric without a denominator. “92% accuracy” may mean accuracy on 200 easy examples, not across millions of live cases. “50 customers” may mean 50 pilots, 50 paid deployments, or 50 enterprise agreements with meaningful recurring revenue.

A second error is confusing automation with autonomy. Many AI products appear autonomous because the interface has no visible human intervention, while operations teams still review every important output. That is not necessarily a problem, but it changes labor assumptions, gross margin, throughput, and liability. Investors should ask where humans enter the process, how many minutes they spend, what escalation rules apply, and whether review quality is measured.

The third error is ignoring the cost of reliability. A 99% system may require extensive retries, fallback models, and manual investigation to achieve that figure. The buyer should request the full cost of an acceptable outcome, including support, security, compliance, and customer integration. Finally, investors should not allow the target’s technical team to control every interview. Independent reviewers, experienced security specialists, sector experts, and former customers can reveal weaknesses that management has normalized.

## When to Act, Pause, or Walk Away

The investor should pause when claims cannot be reproduced, important data rights are unclear, production evidence is limited to demos, or the target has no plan for model-provider changes. A pause may be justified if the company can produce missing records within 30 days, provide a limited pilot with a defined evaluation plan, or contractually allocate risk during a transition. The appropriate response depends on deal size, potential impact, and the buyer’s ability to remediate the weakness after closing.

Investors should consider walking away when the system’s performance depends on undisclosed manual labor, when training or customer data lacks a credible legal basis, when security controls are absent, or when gross margin becomes negative at plausible usage levels. A company that cannot explain a serious hallucination, data leak, or outage may be uninvestable even if its market opportunity is large. The key question is whether the weakness is a manageable gap with a funded remedy or a foundational contradiction between the product claim and the operating reality.

Timing also matters. Structural review should occur before a final investment committee decision, not after a term sheet has established the valuation. In 2026, buyers should revisit the analysis before closing if there is a major model release, acquisition, regulatory change, infrastructure contract, or customer concentration event. A target that passed diligence in January may present a different risk profile in September. The strongest investment decision is therefore not the one that identifies the most impressive model; it is the one that identifies which value drivers are real, which dependencies can fail, and which protections will remain in place after the transaction.

## The Investment Decision Requires Evidence of Durable Performance

The best structural AI due diligence is adversarial, quantified, and connected to the business. It asks whether the product works on representative inputs, whether the company can reproduce its results, whether the data can legally and technically be transferred, whether the system remains stable when vendors change, and whether each successful task produces an acceptable return after infrastructure, labor, security, and compliance costs. It also asks who is accountable when the answer is wrong and whether the company can explain what happened after the fact.

No single metric settles the question. A company can have a weak proprietary model but a valuable workflow, proprietary customer integrations, or unusually strong regulatory controls. Another can own a technically advanced model but lack distribution, data rights, or economic scalability. The investor’s task is to compare those strengths against the dependencies and failure costs. In 2026, that evidence-led comparison is the difference between buying a demonstrable capability and underwriting an assumption that the capability will keep working after the data, market, infrastructure, and regulatory environment move.

Canonical: https://aistructuralreview.com/knowledge/how_should_investors_perform_structural_ai_due_diligence_in_2026.php
Markdown: https://aistructuralreview.com/knowledge/how_should_investors_perform_structural_ai_due_diligence_in_2026.php/index.md